Apex Scientific

21+ access.
Research use only.

Before entering, confirm that you meet the age requirement and understand the research-use limitations that apply to every Apex product.

Leave site

Your acknowledgement is remembered on this device for 30 days.

Research use only Clear product information Free shipping on orders over $200 20% launch offer · Use code APEX101

Compound guide

PT-141

From cellular signaling to what those pathways mean in everyday language.

Overview

A Summary:PT-141

PT-141 is the research name for bremelanotide, a cyclic peptide that activates several melanocortin receptor subtypes.

PT-141, also called bremelanotide, activates melanocortin receptors in the central nervous system. Its best-defined target is the MC4 receptor, which participates in neural networks involved in sexual motivation and desire.

Inside the body

Cellular & MolecularHow PT-141 Functions

These receptors, enzymes, and signaling networks form the primary steps connecting this compound with changes inside cells and tissues.

01Central motivation pathway

Melanocortin-4 receptor

At the cellular or molecular level

Bremelanotide activates melanocortin receptors, with MC4 receptor signaling considered important to its central effects. These G-protein-coupled receptors can alter neuronal cyclic-AMP signaling.

02Behavioral integration

Hypothalamic + limbic circuits

At the cellular or molecular level

Melanocortin signals are integrated across hypothalamic and limbic regions that combine hormonal state, reward, attention, and autonomic response.

03Tolerability pathways

Peripheral melanocortin effects

At the cellular or molecular level

Melanocortin receptors and connected autonomic pathways can affect nausea, flushing, blood pressure, heart rate, and pigmentation-related biology.

In plain English

What those pathways mean.

01

Central motivation pathway

Brain melanocortin networks can influence sexual desire and motivated behavior.

02

Behavioral integration

This central mechanism helps explain changes in desire without requiring a direct local vascular effect.

03

Tolerability pathways

These pathways help explain the approved label's adverse effects and precautions.

How the signals work together

Unlike compounds that act mainly by changing blood flow, PT-141 begins with a brain signal. Melanocortin-receptor activation changes neural communication in pathways that connect motivation, attention, and sexual response.

Read the evidence

Sources BehindThis Guide

FDA bremelanotide mechanism and labelingRECONNECT phase 3 trialsBremelanotide (PT-141) identity record

One important note

Educational Notice

Two phase 3 trials studied a specific bremelanotide formulation in premenopausal women with hypoactive sexual desire disorder. Nausea, flushing, and headache occurred more often than with placebo.

This guide explains cellular mechanisms and published outcomes in everyday language. It is educational information, not medical advice or instructions for personal use. Products offered on this site are intended exclusively for laboratory research and are not for human or veterinary use.